Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Coronavirus: U.S. Government Donates 336,000 Single-dose Johnson & Johnson Vaccines to Mozambique

09/27/2021 | 04:33am EDT

MAPUTO, Mozambique, September 24, 2021/APO Group/ -- Today, at the Mavalane International Airport in Maputo, the United States government donated 336,000 doses of the Johnson & Johnson COVID-19 vaccine to the Mozambican Ministry of Health. Because the vaccine confers immunity in a single dose, this shipment will provide immunity to 336,000 Mozambicans, protecting the health of Mozambicans and preventing dangerous new variants from spreading. Since the storage of Johnson & Johnson vaccines is less onerous than other vaccines, they are easier to distribute.

Our two governments have worked together in a variety of ways to curb COVID-19 in Mozambique

U.S. Ambassador Dennis W. Hearne stated: "As the largest bi-lateral donor of vaccines to Mozambique, the United States is pleased to be part of this coordinated global effort to bring life-saving support to the people of Mozambique. Our two governments have worked together in a variety of ways to curb COVID-19 in Mozambique. These vaccines will fill an important need to successfully fight the virus."

This is the second COVID-19 vaccine delivery. In July, the United States donated 302,400 Johnson and Johnson vaccines. This assistance is another example of the strength of the U.S.-Mozambique relationship, building on decades of health cooperation between Mozambique and the United States. The U.S. Government has provided early and ongoing support for Mozambique's response to the COVID-19 pandemic, including assistance valued at $62.5 million. This assistance includes 50 ventilators donated to the Mozambican Ministry of Health in 2020, personal protective equipment for healthcare workers, laboratory and oxygen equipment, training, and funding for increased medical staff, among other initiatives. For more information on U.S. support for Mozambique's efforts to combat COVID-19, visit this link.

The United States is committed to leading the global COVID-19 response because it is the right thing to do and will make the world safer. The U.S. Government committed $4 billion to the COVAX Facility, becoming the largest donor to the global effort to vaccinate people around the world. The U.S. Government has also purchased one billion vaccines for low-income countries and donated 80 million vaccines from the United States' own supply. For more information on the U.S. government's new Covid commitments, visit this link.

In close collaboration with the Government of the Republic of Mozambique, the U.S. Government provides more than $500 million in annual assistance to improve the quality of education and healthcare, promote economic prosperity, and support the overall development of the nation.

Distributed by APO Group on behalf of U.S. Embassy in Mozambique.


(C) 2021 M2 COMMUNICATIONS, source M2 PressWIRE

All news about JOHNSON & JOHNSON
10/15S&P 500 Posts 1.8% Weekly Gain, Strongest Since July, Amid Positive Start to Q3 Results..
10/15JOHNSON & JOHNSON : COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Us..
10/15STREET COLOR : Global Calendar For Week Ending October 22
10/15JOHNSON & JOHNSON : COVID-19 Vaccine Booster Shot Receives FDA Advisory Panel Recommendati..
10/15FDA panel recommends J&J COVID-19 booster for all recipients who got first shot
10/15JOHNSON & JOHNSON : COVID-19 Vaccine Wins FDA Advisory Panel's Backing as Booster for Adul..
10/15JOHNSON & JOHNSON : Earns a Spot on Fortune's 2021 Change the World List
10/15JOHNSON & JOHNSON : Janssen Gets Positive Opinion on Lung Cancer Treatment From European M..
10/15CORONAVIRUS : Peace Corps Helps Launch Vaccination Campaign in Commune of Mantasoa The cam..
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 93 970 M - -
Net income 2021 22 809 M - -
Net cash 2021 2 466 M - -
P/E ratio 2021 18,7x
Yield 2021 2,58%
Capitalization 425 B 425 B -
EV / Sales 2021 4,49x
EV / Sales 2022 4,21x
Nbr of Employees 134 500
Free-Float 84,3%
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | MarketScreener
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 161,30 $
Average target price 185,83 $
Spread / Average Target 15,2%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.13.20%232 621
MERCK & CO., INC.-4.24%198 283